News
AMD
Study finds that AREDS 2 supplementation helps slow progression of late-stage macular degeneration
While researchers have known that AREDS 2 supplements help slow the progression of AMD from the intermediate stage to the late stage, they wanted to establish whether supplementation could impact t...
age-related macular degeneration
Retrospective study suggests melatonin may decrease risk development of macular degeneration
Melatonin has antioxidant properties and researchers sought to discover if it might provide benefits for eye health.
age-related macular degeneration
Low-dose aspirin offers no benefit against macular degeneration
Australian researchers recently published the results of a study that examined the effects of low-dose aspirin on age-related macular degeneration.
age-related macular degeneration
Study shines light on Saffron's positive affects on vision
Despite it's hefty price tag, saffron, which is a powerful antioxidant, is a popular dietary supplement used for a wide range of ailments including the improvement of cognitive function, mood boost...
age related macular degeneration
Visual hallucinations commonly associated with age-related macular degeneration
Charles Bonnet Syndrome (CBS) is a condition that occurs when people lose some or all of their vision.
AMD
FDA approves Izervay for treatment of geographic atrophy
The Food and Drug Administration (FDA) recently announced their approval of Izervay for treatment of geographic atrophy (GA) secondary to age-related macular degeneration.
age related macular degeneration
AMD patients with visual disability at higher risk of cardiovascular disease
Researchers at Sungkyunkwan University School of Medicine in Korea conducted a nationwide cohort study involving nearly 4 million adults.
age-related macular degeneration
FDA approves first drug to treat geographic atrophy
Geographic atrophy typically affects people over the age of 50 and is one of the main causes of vision loss in the United States.
age-related macular degeneration
Potential cause of AMD identified
Researchers discovered a rare genetic variant that generates malformed proteins that change the stability of the membrane attack complex (MAC).